New European approvals: Pemigatinib - cholangiocarcinoma with a FGFR2 fusion or rearrangementMatthieu Delaye,Simon PernotBulletin du cancer(2021)引用 4|浏览0暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要